A NOVEL APPROACH
TO BRIDGE THE GAP
IN DRUG DEVELOPMENT

Created in November 2012, NEOMED is a not-for-profit, public-private alliance dedicated to drug discovery and development, acting as a foster home for promising assets emerging from academia and biotechnology companies. NEOMED is pioneering an innovative approach to drug development, with a clear mission to bridge the gap between early stage innovations and the healthcare needs of society.

We provide industry-level drug discovery and development expertise and funding to bring promising therapeutic approaches up to human proof-of-concept, a stage where the projects will become attractive to the biopharmaceutical industry or as the basis for the creation of solid start-up companies in Quebec.

NEOMED is sponsored by the pharma industry (AstraZeneca, Pfizer, and Janssen) and the Ministère de l’Économie, de l'Innovation, et des Exportations du Québec. NEOMED operates within the NEOMED Institute at Technoparc Montréal's Saint-Laurent Campus.

YOUR PARTNER IN INNOVATIVE DRUG DEVELOPMENT

mission

YOUR PARTNER IN INNOVATIVE DRUG DEVELOPMENT

mission

mission

mission

YOUR PARTNER IN INNOVATIVE DRUG DEVELOPMENT

mission